QuickView for sequence-specific mRNA binding (biogroup)

1. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
2. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

There were no matches for sequence-specific mRNA binding

1. A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) …
2. Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve …
3. Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autolog…
4. A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With He…
5. RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2